/Investor DB

Hatteras Venture Partners — 2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Bekhealthbekhealth.cominSep 2024 · $4M

BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.

AI & Machine LearningDigital HealthHealthtechBranford, US

Joshua Ransom(Executive Officer)David Levin(Chief Executive Officer)inJosh Brown(Chief Technology Officer)inScott Caflisch(Chief Information Security Officer)inJeff Graham(Chief Data Officer)inJennifer Stacey(Chief Operating Officer)in

Board seatJohn Crumpler· per SEC Form D

Co-investorsConnecticut InnovationsExcelerate Health VenturesMartin VenturesBoston Millennia PartnersSopris Venture Capital

Wildflower Healthwildflowerhealth.cominSeries B · Dec 2024 · $5M

Wildflower Health offers a modular suite of software and services for women's health, combining a digital patient engagement app, a national network of human health advocates and specialists, and value-based care payment model support.

Digital HealthFemTechHealthtechSan Francisco, US

Leah Sparks(CEO & Founder)inKim Russell(Chief Financial Officer of Issuer)in

BoardDan Galles(Director of Issuer)inEzra Mehlman(Director of Issuer)Ralph Sabin(Director of Issuer)in

Board seatJohn Crumpler· per SEC Form D

Co-investorsAllumia VenturesEcho Health VenturesHealthtech CapitalRock Health Capital

Axonis Therapeuticsaxonis.usinOct 2024

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in

BoardCorey . Goodman(Director)inJonathan Leff(Director)in

Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Iaso Ventures+8 more

Iveacareiveacare.comApr 2024 · $27.5M

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.

Deep TechHealthtechMedical DevicesRoseville, US

Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)

BoardKirk Nielsen(Director)in

Co-investorsTreo Ventures, LlcVensana Capital

Synaptrixnovabloc.cominNov 2024

Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief.

BiotechDigital HealthMedical DevicesAlpharetta, US

Shyamy Sastry(Executive Officer, Director)

BoardDoug Reed(Director)Robert Crutchfield(Executive Officer, Director)Anita Watkins(Director)inKurt Jacobus(Director)in

Co-investorsPortal Innovations

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.